文献速递真菌感染医院感染防控新发突发、热带与寄生虫病

印度德里新生儿病房暴发罕见酵母菌血症:Candida blankii

Candida blankii: an emerging yeast in an outbreak of fungaemia in neonates in Delhi, India.
PubMed 文献 · Clin Microbiol Infect · 2020-01-09

印度德里一家多专科医院新生儿重症监护病房在7个月内发现9例新生儿血液培养出罕见多重耐药酵母Candida blankii,均于出生后2-3天发生真菌血症,其中4例死亡,病死率45%。基因组测序证实菌株间高度同源,提示院内传播;该菌对氟康唑及阿尼芬净MIC偏高,FKS1基因存在缺失,提示耐药潜能。

要点

  • 新生儿病房出现C. blankii真菌血症暴发,9例中4例死亡,病死率45%。
  • 该菌易被自动化鉴定系统误判或漏检,需分子测序确认。
  • 氟康唑几何平均MIC为8 mg/L,阿尼芬净几何平均MIC为2 mg/L,提示敏感性降低。

核心结论

  • C. blankii是可引起新生儿院内真菌血症暴发的罕见酵母,对一种或多种抗真菌药物敏感性降低,并具耐药进化潜能。

研究设计与样本

  • 回顾性暴发调查,纳入德里一家多专科医院新生儿重症监护病房7个月内9例血培养C. blankii阳性的新生儿。
  • 菌株采用内转录间隔区及D1/D2区域测序鉴定,按CLSI M27-A3肉汤微量稀释法行抗真菌药敏试验。
  • 采用扩增片段长度多态性分析及Illumina NextSeq500平台全基因组测序分析菌株遗传相关性。

主要发现

  • 9例低出生体重/极低出生体重新生儿在出生后2-3天发生C. blankii真菌血症。
  • 9例均接受氟康唑治疗,其中4例死亡,病死率45%。
  • C. blankii被自动化鉴定系统误判或未能鉴定。
  • 氟康唑几何平均MIC为8 mg/L,高于其他唑类;阿尼芬净几何平均MIC为2 mg/L,亦偏高。
  • 基因组测序证实传播的菌株遗传上大多不可区分,C. blankii基因组显示1,3-β-d-葡聚糖合酶蛋白改变及棘白菌素靶点FKS1基因多处较大缺失。

临床怎么用

  • 新生儿病房出现罕见酵母血流感染时,应警惕C. blankii暴发,常规自动化鉴定不可靠,需分子测序确认。
  • 该菌对氟康唑和阿尼芬净MIC偏高,经验性抗真菌治疗需结合药敏结果调整。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Outbreaks of fungal sepsis due to emerging and rare multidrug-resistant Candida species are increasingly reported in health-care settings. We report an outbreak of fungaemia due to the rare multidrug-resistant yeast Candida blankii in an Indian neonatal unit. MATERIALS AND METHODS: Blood cultures grew C. blankii in nine neonates in the Neonatal Intensive Care Unit of a multispecialty hospital in Delhi during a period of 7 months. Isolates were identified by internal transcribed spacer and D1/D2 region sequencing. Antifungal susceptibility testing was performed by M27-A3 CLSI broth microdilution. To determine genetic relatedness among C. blankii isolates we undertook amplified fragment length polymorphism analysis and DNA sequencing using the Illumina NextSeq500 platform. RESULTS: Candida blankii fungaemia occurred at 2-3 postnatal days in nine low birthweight/very low birthweight neonates. All neonates were treated with fluconazole and four of the nine neonates died, resulting in a case fatality rate of 45%. Candida blankii was misidentified or not identified by automated identification systems. Fluconazole had higher geometric mean (GM) MICs (8 mg/L) than the other azoles. Also, anidulafungin (GM-MIC 2 mg/L) had high MICs. Genome sequencing confirmed transmission of genetically mostly indistinguishable strains. The C. blankii genome showed an altered 1,3-β-d-glucan synthase protein and several larger deletions in the echinocandin target FKS1 gene, suggesting potential for development of antifungal resistance. CONCLUSIONS: The study emphasizes the emergence of a rare and uncommon yeast, C. blankii, with reduced susceptibility to one or more antifungal agents, in nosocomial fungaemia. Genomic insights of this rare yeast are reported using whole-genome sequence typing.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Chowdhary A, Stielow JB, Upadhyaya G, et al. Candida blankii: an emerging yeast in an outbreak of fungaemia in neonates in Delhi, India. Clin Microbiol Infect. 2020. PMID: 31927114. doi:10.1016/j.cmi.2020.01.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。